Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amniotic membrane extract eye drops
- Development stage
- Unknown
- Lead developer
- Tanta University
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Ophthalmic
01
Overview
Amniotic membrane extract eye drops (AMEED) are an investigational biologic therapy developed by researchers at Tanta University for the treatment of resistant or refractory corneal ulcers. Derived from human amniotic membrane, the extract contains a complex biological mixture of growth factors (such as EGF, HGF, and FGF), anti-inflammatory cytokines, and extracellular matrix proteins. These components work synergistically to promote corneal epithelial healing, reduce ocular surface inflammation, and minimize stromal scarring. In clinical settings, AMEED is administered topically as an adjunctive therapy to standard antimicrobial or trophic treatments to accelerate the recovery of ulcers that have failed to respond to conventional management.
- Other names
- Amniotic membrane extractTanta University amniotic membrane extract
02
Targets
MET (Mesenchymal-epithelial transition factor receptor)EGFR (Epidermal growth factor receptor)TGFBR (TGF-beta receptor)FGFR (FGFR family)
Beyond the preview
Go deeper on Amniotic membrane extract eye drops.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amniotic membrane extract eye drops.